You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
22 October 2020
The US Food and Drug Administration (FDA) has implemented labelling changes for non-steroidal anti-inflammatory drugs (NSAIDs), New Zealand has confirmed the date for reverse-switching all medicines containing codeine from non-prescription to prescription status, and Europe's Coordination Group for...
31 March 2020
Paracetamol medicines were the main beneficiary when codeine medicines were reverse-switched from non-prescription to prescription-only status in Australia on 1 February 2018, according to research just published in the Medical Journal of Australia.
17 January 2020
The South African Health Products Regulatory Authority (SAHPRA) is seeking sales data on codeine-containing medicines as it reviews whether such products should remain available without a prescription.
5 December 2019
New Zealand is set to reverse-switch all medicines containing codeine from non-prescription to prescription status.